Cigna modified MM 0106 for continuous glucose monitoring (CGM) systems, effective February 24, 2026. Here's what billing teams need to know.
Cigna Healthcare updated its Diabetes Equipment and Supplies coverage policy, MM 0106, covering CGM devices and supplies. This change affects nine HCPCS codes—including A4238, A4239, A9276, A9277, A9278, E2102, E2103, G0564, and E1399—used by endocrinology practices, DME suppliers, and any provider billing CGM systems for diabetes patients. If your team bills these codes, audit your documentation and prior authorization workflows now, before the February 24, 2026 effective date.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Diabetes Equipment and Supplies |
| Policy Code | MM 0106 |
| Change Type | Modified |
| Effective Date | 2026-02-24 |
| Impact Level | High |
| Specialties Affected | Endocrinology, Primary Care, DME Suppliers, Internal Medicine |
| Key Action | Audit CGM claims against updated medical necessity criteria before February 24, 2026 |
Cigna Continuous Glucose Monitor Coverage Criteria and Medical Necessity Requirements 2026
The Cigna continuous glucose monitor coverage policy under MM 0106 draws a clear line between two CGM categories: adjunctive and nonadjunctive systems. That distinction drives everything—which codes you bill, what documentation you need, and whether your claims pass or deny.
Adjunctive CGMs require the patient to confirm glucose readings with a traditional fingerstick before making treatment decisions. Nonadjunctive CGMs don't—they're approved for dosing decisions on their own. Cigna treats these differently, and your billing needs to reflect that.
For adjunctive systems, Cigna considers E2102 and A4238 medically necessary when criteria in the applicable coverage policy are met. For nonadjunctive systems, E2103 and A4239 are covered under the same framework. The supply allowance codes—A4238 and A4239—cover all CGM supplies in a bundle, so don't unbundle sensors, transmitters, and receivers into separate line items unless you have a specific reason to.
Speaking of separate billing: A9276 (the disposable sensor), A9277 (the external transmitter), and A9278 (the external receiver/monitor) are each considered medically necessary when criteria are met. These codes apply to nondurable medical equipment—not implantable systems. That matters for your DME billing documentation.
For the implantable 365-day system, G0564 covers the creation of a subcutaneous pocket with sensor insertion. This is a procedure code, not a supply code—it requires different documentation than your DME codes, and prior authorization requirements may apply separately.
The real issue here is documentation. Cigna CGM coverage requires medical necessity to be established at the patient level. Generic diabetes diagnoses won't carry a claim. Your records need to show the patient's diabetes type, treatment regimen, and clinical need for continuous monitoring versus standard glucose testing.
If you're billing CGM supplies to Cigna and haven't reviewed your documentation templates against the updated MM 0106 criteria, do that before February 24, 2026. A claim denial on a CGM bundle is expensive—these aren't low-dollar line items.
Cigna CGM Exclusions and Non-Covered Indications
One code in this policy doesn't get the medical necessity designation: E1399.
E1399 is the catch-all HCPCS code for miscellaneous durable medical equipment. Cigna considers it experimental, investigational, and unproven in this context. That means if your team is billing E1399 for CGM-adjacent equipment that doesn't fit a specific code, Cigna will deny it.
This is a pattern you've seen before—payers use the E&I designation on miscellaneous codes to close billing workarounds. The message here is clear: if a CGM device or supply doesn't map to A9276, A9277, A9278, A4238, A4239, E2102, E2103, or G0564, Cigna isn't covering it under this policy.
Don't use E1399 as a fallback. If you have a CGM component that doesn't fit an existing code, talk to your billing consultant before you submit. Billing E1399 for CGM equipment against Cigna is a denial waiting to happen.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Adjunctive nonimplanted CGM device | Covered | E2102 | Medical necessity criteria must be met |
| Adjunctive CGM supply allowance | Covered | A4238 | Bundles all supplies; do not unbundle |
| Nonadjunctive nonimplanted CGM device | Covered | E2103 | Medical necessity criteria must be met |
| Nonadjunctive CGM supply allowance | Covered | A4239 | Bundles all supplies; do not unbundle |
| Disposable subcutaneous sensor (nondurable DME) | Covered | A9276 | For nondurable equipment CGM systems only |
| External transmitter (nondurable DME) | Covered | A9277 | For nondurable equipment CGM systems only |
| External receiver/monitor (nondurable DME) | Covered | A9278 | For nondurable equipment CGM systems only |
| Implantable 365-day interstitial glucose sensor insertion | Covered | G0564 | Procedure code; verify prior authorization requirements |
| Miscellaneous DME (CGM context) | Experimental/Investigational/Unproven | E1399 | Denied under this policy; do not use as a CGM billing workaround |
Cigna CGM Billing Guidelines and Action Items 2026
These are direct steps for your billing and revenue cycle team. Tie each one to the February 24, 2026 effective date.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for all nine HCPCS codes before February 24, 2026. Pull every open or recurring CGM claim against Cigna. Confirm each maps to A4238, A4239, A9276, A9277, A9278, E2102, E2103, or G0564—not E1399. |
| 2 | Remove E1399 from your CGM charge capture templates. If your system uses E1399 as a fallback for miscellaneous CGM equipment, flag it now. Any Cigna claim using E1399 for CGM will be denied as experimental under MM 0106. |
| 3 | Verify that adjunctive and nonadjunctive CGM systems are billed with the correct code pair. Adjunctive systems use E2102 and A4238. Nonadjunctive systems use E2103 and A4239. Mixing these up creates a mismatch between the device and supply codes, which triggers reviews and denials. |
| 4 | Check prior authorization requirements for G0564 before scheduling implantable sensor procedures. G0564 covers a surgical procedure—subcutaneous pocket creation with sensor insertion. Prior auth workflows for procedures differ from DME prior auth. Confirm Cigna's requirements for your plan type and patient population before submitting. |
| 5 | Update your medical necessity documentation templates to reflect CGM-specific criteria. Generic diabetes documentation isn't enough. Your clinical records need to show the specific indication for CGM—diabetes type, current treatment regimen, monitoring frequency requirements, and the clinical rationale for continuous versus episodic glucose testing. |
| 6 | Brief your DME billing staff on the nondurable equipment distinction. Codes A9276, A9277, and A9278 apply specifically to nondurable CGM equipment. These are not interchangeable with codes for implantable systems. If your practice handles both, make sure your billing team knows which code set applies to which device. |
| 7 | If you're uncertain how MM 0106 applies to your specific payer contracts or patient mix, talk to your compliance officer before February 24, 2026. Cigna CGM billing guidelines interact with plan-level variations, and the stakes are high enough that a second set of eyes is worth it. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for CGM Systems Under MM 0106
Covered HCPCS Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| A4238 | HCPCS | Supply allowance for adjunctive, nonimplanted continuous glucose monitor (CGM); includes all supplies |
| A4239 | HCPCS | Supply allowance for nonadjunctive, nonimplanted continuous glucose monitor (CGM); includes all supplies |
| A9276 | HCPCS | Sensor; invasive (e.g., subcutaneous), disposable, for use with nondurable medical equipment interstitial continuous glucose monitor |
| A9277 | HCPCS | Transmitter; external, for use with nondurable medical equipment interstitial continuous glucose monitor |
| A9278 | HCPCS | Receiver (monitor); external, for use with nondurable medical equipment interstitial continuous glucose monitor |
| E2102 | HCPCS | Adjunctive, nonimplanted continuous glucose monitor (CGM) or receiver |
| E2103 | HCPCS | Nonadjunctive, nonimplanted continuous glucose monitor (CGM) or receiver |
| G0564 | HCPCS | Creation of subcutaneous pocket with insertion of 365-day implantable interstitial glucose sensor, including system activation |
Not Covered / Experimental HCPCS Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| E1399 | HCPCS | Durable medical equipment, miscellaneous | Considered Experimental/Investigational/Unproven when used for CGM under MM 0106 |
Key ICD-10-CM Diagnosis Codes
The MM 0106 policy data does not list specific ICD-10-CM codes. Work with your clinical documentation team to ensure the appropriate diabetes diagnosis codes (from the E10–E13 range) are present and support the medical necessity criteria in the coverage policy before submitting claims.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.